Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted)
DISCLAIMER: THIS PAGE IS INTENDED FOR MEMBERS OF THE GENERAL PUBLIC IN TAIWAN ONLY.
The information provided on this site is intended for general information and education for Taiwan-based members of the public and is not intended to be a substitute for the advice provided by a physician or other qualified healthcare professional.
Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
Important information
For more information about the NuvaxovidTM COVID-19 Vaccine (recombinant, adjuvanted), view the PDF file of the Product Information Leaflet.
If you have any questions or concerns regarding NuvaxovidTM COVID-19 Vaccine (recombinant, adjuvanted), please speak to your healthcare professional.
This link below will allow you to download/view the PDF SmPC document.
This link below will allow you to download/view the PL document.
How to contact Novavax
If you are concerned about any potential side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the Patient Medication Information.
09:00 - 17:00
Monday - Friday
More information is available on our global website, novavax.com.
Our location:
Novavax, Inc.
21 Firstfield Road
Gaithersburg, MD 20878